Neuro‑Oncology Clinical Trials Leadership at the University of Michigan
Dr. Kim R50 Research Specialist Clinician 2022
This work supports clinical trials and care improvements for people with brain tumors and brain metastases.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Michigan at Ann Arbor NIH-funded |
| Lab location | 1 site (Ann Arbor, United States) |
| Project ID | NIH-11283981 on NIH RePORTER |
What this research studies
Dr. Kim leads the neuro‑oncology clinical trials program at the University of Michigan and helps run and expand trials that include treatment and observational studies for central nervous system (CNS) cancers. She serves as site principal investigator on NCI-funded trials, co‑leads national brain metastases groups, and helps bring multi‑site studies into practice. Her efforts include broadening trial eligibility, developing investigator‑initiated studies, and working with guideline committees to translate trial results into care changes. Patients may access trials at Michigan or at collaborating NCI network sites she helps organize.
Who could benefit from this research
Good fit: Ideal candidates are people with primary brain tumors or brain metastases who are eligible for clinical trials at the University of Michigan or participating NCI network sites.
Not a fit: People without CNS cancers or those who do not meet trial eligibility criteria would not directly benefit from these trial‑focused activities.
Why it matters
Potential benefit: If successful, this work could increase patient access to new therapies, make trials available to more people, and speed adoption of better care for CNS cancers.
How similar studies have performed: National clinical trials and collaborative networks in neuro‑oncology have previously led to practice‑changing treatments, and this effort builds on that established clinical trial infrastructure.
Where this research is happening
Ann Arbor, United States
- University of Michigan at Ann Arbor — Ann Arbor, United States (Active)
Researchers
- Principal investigator: Kim, Michelle Miran — University of Michigan at Ann Arbor
- Study coordinator: Kim, Michelle Miran
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.